Dr. Johnson's research encompasses three main areas: Anaerobic Microbiology, Microbial Systematics & Taxonomy, and The Human Microbiome.  As a new Principal Investigator at OSU-CHS, her laboratory will focus on the discovery of novel anaerobes and their syntrophic partners with a view towards tailored microbiome modulation and precision therapeutics. Dr. Johnson brings with her a strong track record in acquisition, implementation, and management of clinical & industry related research projects across America and Europe.  

• Anaerobic Culturomics approach to novel taxa isolation
• Antimicrobial peptide discovery and translational applications 
• Next-generation pre/probiotics
• Methanogenic syntrophy in gut health and environmental mitigation strategies
• Associations of the Microbiome and host health, including: 
  
  • Metabolic Syndrome
  • Cholecystitis
  • Type II Diabetes
  • Cognition (gut-brain-axis)